Abstract

HomeArteriosclerosis, Thrombosis, and Vascular BiologyVol. 42, No. 8Correction to: Macrophage ALDH2 (Aldehyde Dehydrogenase 2) Stabilizing Rac2 Is Required for Efferocytosis Internalization and Reduction of Atherosclerosis Development Free AccessCorrectionPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessCorrectionPDF/EPUBCorrection to: Macrophage ALDH2 (Aldehyde Dehydrogenase 2) Stabilizing Rac2 Is Required for Efferocytosis Internalization and Reduction of Atherosclerosis Development Originally published27 Jul 2022https://doi.org/10.1161/ATV.0000000000000156Arteriosclerosis, Thrombosis, and Vascular Biology. 2022;42:e252This article corrects the followingMacrophage ALDH2 (Aldehyde Dehydrogenase 2) Stabilizing Rac2 Is Required for Efferocytosis Internalization and Reduction of Atherosclerosis DevelopmentIn the article by Zhang et al, “Macrophage ALDH2 (Aldehyde Dehydrogenase 2) Stabilizing Rac2 Is Required for Efferocytosis Internalization and Reduction of Atherosclerosis Development,” which published in the June 2022 issue of the journal (Arterioscler Thromb Vasc Biol. 2022;42:700–716. doi: 10.1161/ATVBAHA.121.317204), corrections were needed.The ORCID logo in the author byline should have been associated with Dr Feng Xu.In the Figure 7 legend, “acute coronary syndromes (ACs)” should have been “apoptotic cells (ACs)”.The publisher apologizes for the errors.This correction has been made to the current online version of the article, which is available at www.ahajournals.org/doi/10.1161/ATVBAHA.121.317204. Previous Back to top Next FiguresReferencesRelatedDetailsRelated articlesMacrophage ALDH2 (Aldehyde Dehydrogenase 2) Stabilizing Rac2 Is Required for Efferocytosis Internalization and Reduction of Atherosclerosis DevelopmentJian Zhang, et al. Arteriosclerosis, Thrombosis, and Vascular Biology. 2022;42:700-716 August 2022Vol 42, Issue 8 Advertisement Article InformationMetrics © 2022 American Heart Association, Inc.https://doi.org/10.1161/ATV.0000000000000156PMID: 35895806 Originally publishedJuly 27, 2022 PDF download Advertisement

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call